Augment Therapy is a MedTech firm offering AR gamified rehabilitative healthcare programs, accessible on a smartphone or tablet. The company’s flagship platform ‘ARWell’ is marketed in two versions. ARWell Pro is offered to healthcare providers to prescribe to specific patients, while ARWell is accessible by all individuals without a prescription.
The platform offers a library of gamified exercises (skiing, surfing, obstacle courses, yoga) in 3D worlds to improve strength, coordination, and endurance. User movements are automatically tracked through a full-body motion capture solution (leveraging existing hardware on a smartphone), backed by its proprietary ‘MOCAST’ technology.
Healthcare providers can monitor patients' progress remotely through a therapist portal. Additionally, the company’s programs are designed by a team of physical therapists for evidence-based outcomes.
The company generates revenue on a subscription-basis.
Key customers and partnerships
In March 2023, the company announced a strategic pilot program with CareSource to provide its rehabilitation services in four partner locations in Ohio.
Funding and financials
In November 2023, Augment Therapy raised USD 2.7 million in a seed plus funding round from BlueTree Capital Group, CareSource and other investors. Funds were earmarked to expand Augment Therapy's product line, improve research validation, and bolster market traction.
Previously, in May 2023, the company received a USD 1 million donation from CareSource to help ensure equitable access to its solutions.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.